Announcements
- Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds
- Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain
- Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
Key statistics
On Friday, Sonnet Biotherapeutics Holdings Inc (H3D:BER) closed at 0.184, 0.00% above its 52-week low of 0.184, set on Sep 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | 0.00 |
Low | 0.00 |
Bid | -- |
Offer | -- |
Previous close | 0.184 |
Average volume | -- |
---|---|
Shares outstanding | 3.11m |
Free float | 2.83m |
P/E (TTM) | -- |
Market cap | 2.83m USD |
EPS (TTM) | -5.28 USD |
Data delayed at least 15 minutes, as of Sep 01 2023 07:09 BST.
More ▼